handn18_laptop
handn18_phone

Schedule of Events

Wednesday, February 14, 2018

4:00 p.m. - 6:00 p.m.
Registration

Thursday, February 15, 2018

7:00 a.m. - 5:30 p.m.
Registration

7:00 a.m. - 8:00 a.m.
Continental Breakfast

7:50 a.m. - 8:00 a.m.
Day One Welcome
Robert I. Haddad, MD, Dana-Farber Cancer Institute, Boston

8:00 a.m. - 9:30 a.m.
General Session I: Oral Cavity
Moderator: Maie St. John, MD, PhD, UCLA Medical Center, Los Angeles

  • How Better Radiation Can Impact Quality of Life
    Jolie Ringash, MD, FRCPC, MSc, Princess Margaret Hospital, Toronto 
  • Reconstruction
    P. Daniel Knott, MD, University of California San Francisco, San Francisco 
  • Pre-operative Therapy and Chemoprevention
    William Nassib William Jr., MD, MD Anderson Cancer Center, Houston 

9:30 a.m. - 10:00 a.m.
Coffee Break

10:00 a.m. - 10:45 a.m.
Keynote I: Immunotherapy in Head and Neck Cancer 
Moderator: Robert I. Haddad, MD, Dana-Farber Cancer Institute, Boston

  • Julie E. Bauman, MD, MPH, University of Arizona, Tucson, Arizona

10:45 a.m. - 12:15 p.m.
K. Kian Ang, MD, PhD, FASTRO, Commemorative Plenary Session
Moderator: Randall J. Kimple, MD, PhD, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 

12:15 p.m. - 1:15 p.m.
Lunch

Expert Office Hours

  • Jimmy Caudell, MD, PhD, Moffitt Cancer Center, Tampa, Florida 
  • Kathryn A. Gold, MD, University of California San Diego, La Jolla, California 
  • Patrick Ha, MD, University of California, San Francisco 
  • Quynh-Thu Le, MD, FASTRO, Stanford University, Stanford, California 
  • Cherie-Ann O. Nathan, MD, Louisiana State University Health Sciences Center, Shreveport, Louisiana 
  • Maie St. John, MD, PhD, UCLA Medical Center, Los Angeles 
  • Francis P. Worden, MD, University of Michigan Health System Comprehensive Cancer Center, Ann Arbor, Michigan


1:15 p.m. - 2:45 p.m.
General Session II: Tonsil and Base of Tongue
Moderator: Eduardo Mendez, MD, MS, FACS, University of Washington, Seattle

  • Dose/Volume De-escalation Protocols
    Jimmy Caudell, MD, PhD, Moffitt Cancer Center, Tampa, Florida 
  • Does Chemoselection Have a Role in Oropharynx Cancer?
    Ranee Mehra, MD, Johns Hopkins Hospital, Baltimore 
  • Minimally Invasive Procedures
    Chad Zender, MD, FACS, Case Western Medical Center, Cleveland 

2:45 p.m. - 3:45 p.m.
General Session III: Nasopharynx
Moderator: Beth Beadle, MD, Stanford University, Palo Alto, California

  • Biological Selection for Treatment of Nasopharyngeal Cancer
    Nancy Y. Lee, MD, FASTRO, Memorial Sloan Kettering Cancer Center, New York 
  • Timing of Chemotherapy: Induction versus Adjuvant
    Joseph Wee, MD, MBBS, FRCR, FAMS, National Cancer Centre Singapore 
  • Particle Beam Therapy for NPC Re-irradiation
    Jiade Lu, MD, MBA, Shanghai Proton and Heavy Ion Center, Shanghai, China


3:45 p.m. - 4:15 p.m.
Coffee Break

4:15 p.m. - 5:30 p.m.
Tumor Board: Early Stage Disease
Moderator: Danielle N. Margalit, MD, MPH, Dana-Farber Cancer Institute, Boston

  • David Adelstein, MD, Cleveland Clinic, Cleveland 
  • Alexander Lin, MD, University of Pennsylvania, Philadelphia 
  • Ellie Maghami, MD, FACS, City of Hope, Duarte, California 

5:30 p.m. - 6:30 p.m.
Poster Viewing Session and Reception

Friday, February 16, 2018

7:00 a.m. - 6:15 p.m.
Registration

7:00 a.m. - 8:00 a.m.
Continental Breakfast

7:55 a.m. - 8:00 a.m.
Day Two Welcome
Quynh-Thu Le, MD, FASTRO, Stanford University, Stanford, California

8:00 a.m. - 9:30 a.m.
General Session IV: Larynx
Moderator: Anna M. Pou, MD, FACS, Our Lady of the Lake Physician Group, Baton Rouge, Louisiana

  • Preserving the Functional Larynx for Locally Advanced Larynx Cancer
    Wendy Hara, MD, Stanford University, Palo Alto, California
  • Systemic Therapy for Larynx Cancer
    Barbara Ann Burtness, MD, Yale Cancer Center, New Haven, Connecticut
  • Minimally Invasive Approaches in Larynx Cancer
    Mihir R. Patel, MD, Emory University School of Medicine, Atlanta

9:30 a.m. - 10:15 a.m.
Keynote II: New AJCC/UICC Staging System
Moderator: Quynh-Thu Le, MD, FASTRO, Stanford University, Stanford, California

  • Brian O’Sullivan, MD, FASTRO, Princess Margaret Hospital, Toronto, Canada


10:15 a.m. - 10:45 a.m.
Coffee Break

10:45 a.m. - 12:30 p.m.
General Session V: Salivary Glands and Thyroid
Moderator: Patrick Ha, MD, University of California, San Francisco

  • Pathology Review
    Raja Seethala, MD, University of Pittsburgh Medical Center, Pittsburgh
  • Radiation Treatment for Salivary Gland and Thyroid Tumors
    Sue S. Yom, MD, PhD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco 
  • Molecularly Targeted Therapy for Salivary Cancer
    Nicole G. Chau, MD, Dana-Farber Cancer Institute, Boston 
  • Molecular Advances in Thyroid Cancer Management
    Herbert Chen, MD, University of Alabama School of Medicine, Birmingham, Alabama 

12:30 p.m. - 1:30 p.m.
Lunch

Trainee and Early-career Networking Luncheon

  • Robert I. Haddad, MD, Dana-Farber Cancer Institute, Boston
  • Randall J. Kimple, MD, PhD, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
  • Maie St. John, MD, PhD, UCLA Medical Center, Los Angeles

1:30 p.m. - 3:00 p.m.
Oral Abstract Session
Francis P. Worden, MD, University of Michigan Health System Comprehensive Cancer Center, Ann Arbor, Michigan 

3:00 p.m. - 4:30 p.m.
Breakout Session I: Early Research and Models
Moderator: Neil Hayes, MD, MPH, UNC School of Medicine, Chapel Hill, North Carolina

  • Radiomics and Mathematical Models
    Heiko Enderling, PhD, Moffitt Cancer Center, Tampa, Florida 
  • Immune Targeting in Head and Neck Squamous Cell Carcinoma: PD-L1, Vaccines and Beyond
    Scott E. Strome, MD, University of Maryland, Baltimore
  • Humanized Laboratory Models to Study the Tumor-stroma Interaction and Translate Immune-directed Therapies
    Antonio Jimeno, MD, PHD, University of Colorado, Aurora, Colorado


Breakout Session II: Survivorship and Acute and Late Effects

Moderator: Barbara Murphy, MD, Vanderbilt University School of Medicine, Nashville, Tennessee

  • Dental Issues for Patients Receiving Radiation
    Evan B. Rosen, DMD, MPH, FACP, Memorial Sloan Kettering Cancer Center, New York 
  • Surveillance and Management of Late Effects of Head and Neck Cancer Therapy
    Katherine A. Hutcheson, PhD, MD Anderson Cancer Center, Houston
  • Management of Mucositis Secondary to Cancer Therapy
    Nikhil G. Rao, MD, Florida Hospital, Orlando, Florida

4:30 p.m. - 5:00 p.m.
Coffee Break

5:00 p.m. - 6:15 p.m.
Tumor Board: Advanced Disease
Moderator: Kathryn A. Gold, MD, University of California San Diego, La Jolla, California

  • June Corry, MD, MBBS, FRACP, FRANZCR, St. Vincent’s Hospital, Fitzroy, Australia
  • Jonathan Irish, MD, MSc, FRCSC, FACS, Princess Margaret Cancer Centre, Toronto
  • Everett Vokes, MD, University of Chicago, Chicago

Saturday, February 17, 2018

7:00 a.m. - 12:00 p.m.
Registration

7:00 a.m. - 8:00 a.m.
Continental Breakfast

7:55 a.m. - 8:00 a.m.
Day Three Welcome
Cherie-Ann O. Nathan, MD, Louisiana State University Health Sciences Center, Shreveport, Louisiana

8:00 a.m. - 9:30 a.m.
General Session VI: Immunotherapy Advances in Head and Neck Cancer
Moderator: Robert L. Ferris, MD, PhD, FACS, University of Pittsburgh Cancer Institute, Pittsburgh

  • Immunotherapy in Recurrent Disease
    Michael K. Gibson, MD, PhD, FACP, University Hospitals Cleveland Medical Center, Cleveland 
  • Immunotherapy in Definitive Treatment in Combination with Radiotherapy (RT) and ChemoRT
    Andrew B. Sharabi, MD, PhD, UC San Diego Health, Moores Cancer Center, La Jolla, California
  • Immunotherapy in Neo-adjuvant Treatment
    Ravindra Uppaluri, MD, PhD, Dana-Farber Cancer Institute, Boston

9:30 a.m. - 10:00 a.m.
Coffee Break

10:00 a.m. - 10:45 a.m.
Keynote III: Melanoma of the Head and Neck
Moderator: Cherie-Ann O. Nathan, MD, Louisiana State University Health Sciences Center, Shreveport, Louisiana

  • Carol Rossier Bradford, MD, University of Michigan Health System, Ann Arbor, Michigan


10:45 a.m. - 12:00 p.m.
Tumor Board: Rare Tumors and Non-Melanoma Skin Cancer of the Head and Neck
Moderator: Cherie-Ann O. Nathan, MD, Louisiana State University Health Sciences Center, Shreveport, Louisiana

  • Nishant Agrawal, MD, University of Chicago, Chicago
  • David M. Brizel, MD, FASTRO, Duke Cancer Institute, Durham, North Carolina
  • Ezra Cohen, MD, UC San Diego Health, Moores Cancer Center, La Jolla, California 
Copyright © 2017 American Society for Radiation Oncology | Conflict of InterestTerms of Use | Privacy Policy | Contact Us 
251 18th Street South, 8th Floor, Arlington, VA 22202 | Phone: 703-502-1550 | Fax: 703-502-7852